Deprescribing in older people.

Br J Hosp Med (Lond)

Department of Geriatric Medicine, University Hospital Llandough, Cardiff University, Penarth, UK.

Published: January 2020

Polypharmacy and multimorbidity are both currently rising. The number of medicines taken is the single biggest predictor of adverse drug events. Deprescribing is an approach to managing polypharmacy and reducing adverse outcomes. Multiple international evidence-based guidelines are emerging to promote discontinuation of high-risk medications, and use of alternative medical and non-pharmacological management. This review outlines the evidence base behind deprescribing, and suggests some pragmatic approaches to decision making around medication review.

Download full-text PDF

Source
http://dx.doi.org/10.12968/hmed.2019.0213DOI Listing

Publication Analysis

Top Keywords

deprescribing older
4
older people
4
people polypharmacy
4
polypharmacy multimorbidity
4
multimorbidity currently
4
currently rising
4
rising number
4
number medicines
4
medicines single
4
single biggest
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!